Investigational Site Number : 3800005

Brescia 25123

0 studies enrolling now · 2 studies all time

What they study most

Dermatitis Atopic, Plasma Cell Myeloma Recurrent

Studies at this site

• Open Label, Long-term Study Evaluating Safety and Efficacy of Subcutaneous Amlitelimab in Participants Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis — Running, not enrolling
• SC Versus IV Isatuximab in Combination With Pomalidomide and Dexamethasone in RRMM — Running, not enrolling